Innovators and early adopters in the diffusion of innovations: A literature review
Despite accounting for a very small percentage of the population that adopts an innovation,
the 'innovators' and 'early adopters'—representing the two earliest groups of individuals to …
the 'innovators' and 'early adopters'—representing the two earliest groups of individuals to …
[HTML][HTML] Barriers for access to new medicines: searching for the balance between rising costs and limited budgets
B Godman, A Bucsics, P Vella Bonanno… - Frontiers in Public …, 2018 - frontiersin.org
Introduction: There is continued unmet medical need for new medicines across countries
especially for cancer, immunological diseases, and orphan diseases. However, there are …
especially for cancer, immunological diseases, and orphan diseases. However, there are …
Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries
Importance The association between industry payments to physicians and prescribing rates
of the brand-name medications that are being promoted is controversial. In the United …
of the brand-name medications that are being promoted is controversial. In the United …
Factors influencing prescribing decisions of physicians: a review
BACKGROUND: The pharmaceutical bill is increasing at an alarming rate. The physician
practice variation has a pronounced effect on healthcare spending. A number of factors can …
practice variation has a pronounced effect on healthcare spending. A number of factors can …
[HTML][HTML] Socioeconomic aspects of incretin-based therapy
Incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1
RAs), have demonstrated cardiovascular benefits in people with type 2 diabetes. However …
RAs), have demonstrated cardiovascular benefits in people with type 2 diabetes. However …
Differences in breast and colorectal cancer screening adherence among women residing in urban and rural communities in the United States
Importance Screening for breast and colorectal cancer has resulted in reductions in
mortality; however, questions remain regarding how these interventions are being diffused …
mortality; however, questions remain regarding how these interventions are being diffused …
[HTML][HTML] Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review
K Medlinskiene, J Tomlinson, I Marques… - BMC health services …, 2021 - Springer
Background Implementation and uptake of novel and cost-effective medicines can improve
patient health outcomes and healthcare efficiency. However, the uptake of new medicines …
patient health outcomes and healthcare efficiency. However, the uptake of new medicines …
[HTML][HTML] Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes–a Danish nationwide …
AC Falkentoft, J Andersen, ME Malik… - The Lancet Regional …, 2022 - thelancet.com
Background Low socioeconomic position may affect initiation of sodium-glucose
cotransporter-2 inhibitors (SGLT-2i) and glucacon-like-peptide-1 receptor agonists (GLP …
cotransporter-2 inhibitors (SGLT-2i) and glucacon-like-peptide-1 receptor agonists (GLP …
[HTML][HTML] Uptake of biosimilar infliximab in the UK, France, Japan, and Korea: budget savings or market expansion across countries?
Y Kim, HY Kwon, B Godman, E Moorkens… - Frontiers in …, 2020 - frontiersin.org
Objective To compare the market dynamics of biosimilar infliximab among four Organization
for Economic Cooperation and Development (OECD) countries (UK, France, Japan, and …
for Economic Cooperation and Development (OECD) countries (UK, France, Japan, and …
Deficits and disparities in early uptake of glucagon-like peptide 1 receptor agonists and SGLT2i among medicare-insured adults following a new diagnosis of …
SJ Cromer, JC Lauffenburger, R Levin… - Diabetes Care, 2023 - Am Diabetes Assoc
OBJECTIVE To examine the association of race/ethnicity and socioeconomic deprivation
with initiation of guideline-recommended diabetes medications with cardiovascular benefit …
with initiation of guideline-recommended diabetes medications with cardiovascular benefit …